相似文献
1
Nanomaterials for cancer immunotherapy.
Biomaterials. 2017 Dec;148:16-30. doi: 10.1016/j.biomaterials.2017.09.017. Epub 2017 Sep 17.
2
Drug Delivery for Cancer Immunotherapy and Vaccines.
Pharm Nanotechnol. 2018;6(4):232-244. doi: 10.2174/2211738506666180918122337.
3
Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
Adv Mater. 2019 Aug;31(34):e1803322. doi: 10.1002/adma.201803322. Epub 2019 Feb 18.
4
Nanomaterials for T-cell cancer immunotherapy.
Nat Nanotechnol. 2021 Jan;16(1):25-36. doi: 10.1038/s41565-020-00822-y. Epub 2021 Jan 12.
5
Immunologic Targeting of Cancer Stem Cells.
Surg Oncol Clin N Am. 2019 Jul;28(3):431-445. doi: 10.1016/j.soc.2019.02.010. Epub 2019 Apr 10.
6
Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Cancer Sci. 2015 Feb;106(2):134-42. doi: 10.1111/cas.12584. Epub 2015 Jan 16.
7
Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy.
AAPS J. 2019 May 17;21(4):64. doi: 10.1208/s12248-019-0333-y.
8
CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
Hum Vaccin Immunother. 2014;10(10):3090-100. doi: 10.4161/hv.29767.
9
DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
Pharmacol Ther. 2016 Sep;165:32-49. doi: 10.1016/j.pharmthera.2016.05.004. Epub 2016 May 24.
10
Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy.
Chemistry. 2024 Jun 6;30(32):e202400425. doi: 10.1002/chem.202400425. Epub 2024 May 2.
引用本文的文献
1
Recent Advancement in MRI-Based Nanotheranostic Agents for Tumor Diagnosis and Therapy Integration.
Int J Nanomedicine. 2025 Aug 29;20:10503-10540. doi: 10.2147/IJN.S529003. eCollection 2025.
2
Global research trends on epigenetics and cancer: A bibliometric analysis.
Medicine (Baltimore). 2025 Aug 15;104(33):e43197. doi: 10.1097/MD.0000000000043197.
3
Biomimetic nanovaccines in cancer therapy: mechanisms, efficacy, and clinical translation.
Mater Today Bio. 2025 Jul 18;34:102116. doi: 10.1016/j.mtbio.2025.102116. eCollection 2025 Oct.
4
Metal-based nanomedicines for cancer theranostics.
Mil Med Res. 2025 Jul 30;12(1):41. doi: 10.1186/s40779-025-00627-x.
5
Nanoparticles induced cuproptosis to enhance antitumor immunotherapy.
J Nanobiotechnology. 2025 Jul 28;23(1):544. doi: 10.1186/s12951-025-03616-3.
6
Immunomodulatory nanoplatforms with multiple mechanisms of action in cancer treatment.
Nanomedicine (Lond). 2025 Jun;20(11):1321-1338. doi: 10.1080/17435889.2025.2500906. Epub 2025 May 7.
7
Nanoparticle-based biomolecules in cancer diagnosis, therapy, drug delivery and prognosis.
Front Dent Med. 2024 Nov 21;5:1482166. doi: 10.3389/fdmed.2024.1482166. eCollection 2024.
8
Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system.
Mater Today Bio. 2025 Jan 4;31:101457. doi: 10.1016/j.mtbio.2025.101457. eCollection 2025 Apr.
9
Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment.
Mol Cancer. 2024 Nov 1;23(1):246. doi: 10.1186/s12943-024-02161-1.
10
Tumor targeting peptide TMTP1 modified Antigen capture Nano-vaccine combined with chemotherapy and PD-L1 blockade effectively inhibits growth of ovarian cancer.
J Nanobiotechnology. 2024 Aug 13;22(1):483. doi: 10.1186/s12951-024-02744-6.
本文引用的文献
1
Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer.
ACS Nano. 2017 Sep 26;11(9):8690-8706. doi: 10.1021/acsnano.7b01786. Epub 2017 Aug 28.
2
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy.
Nat Nanotechnol. 2017 Sep;12(9):877-882. doi: 10.1038/nnano.2017.113. Epub 2017 Jun 26.
3
A STING-activating nanovaccine for cancer immunotherapy.
Nat Nanotechnol. 2017 Jul;12(7):648-654. doi: 10.1038/nnano.2017.52. Epub 2017 Apr 24.
4
Polymeric Materials for Gene Delivery and DNA Vaccination.
Adv Mater. 2009 Feb 23;21(8):847-867. doi: 10.1002/adma.200801478. Epub 2008 Dec 4.
5
Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis.
Vaccine. 2017 May 2;35(19):2550-2557. doi: 10.1016/j.vaccine.2017.03.067. Epub 2017 Apr 3.
6
Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1.
Oncogene. 2017 Aug;36(31):4457-4468. doi: 10.1038/onc.2017.65. Epub 2017 Apr 3.
7
Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
ACS Nano. 2017 May 23;11(5):4463-4474. doi: 10.1021/acsnano.7b00715. Epub 2017 Apr 21.
8
Efficient Nanovaccine Delivery in Cancer Immunotherapy.
ACS Nano. 2017 Mar 28;11(3):2387-2392. doi: 10.1021/acsnano.7b00978. Epub 2017 Mar 9.
9
Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors.
Onco Targets Ther. 2017 Jan 21;10:463-476. doi: 10.2147/OTT.S119362. eCollection 2017.
10
New strategies for cancer immunotherapy: targeting regulatory T cells.
Genome Med. 2017 Jan 27;9(1):10. doi: 10.1186/s13073-017-0402-8.
Zotero 插件